person · Reporting owner
HUNTER CHRISTOPHER H.
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Acadia Healthcare Company, Inc.ACHC · Entity 4312 | Director · Chief Executive Officer | June 26, 2025 | June 27, 2025 |
| AfterNext HealthTech Acquisition Corp.AFTR · Entity 131185 | Director | August 11, 2021 | August 11, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Acadia Healthcare Company, Inc.
Report date June 26, 2025 · Filed June 27, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 258,530 |
Reported balance
After 2025-06-26 transaction · row 1
1 source rowRow 1 · 2025-06-26 · Tax withholding · Disposed 5,464 · Balance 258,530 |
AfterNext HealthTech Acquisition Corp.
Report date August 11, 2021 · Filed August 11, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class F Ordinary Shares, par value $0.0001SEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-08-11 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: The reporting person owns 40,000 Class F ordinary shares, par value $0.0001 per share, which are convertible on a one-for-one basis into Class A Ordinary Shares, par value $0.0001 per share, automatically on the day of the closing of the Issuer's initial business combination. The Class F Ordinary Shares have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person owns 40,000 Class F ordinary shares, par value $0.0001 per share, which are convertible on a one-for-one basis into Class A Ordinary Shares, par value $0.0001 per share, automatically on the day of the closing of the Issuer's initial business combination. The Class F Ordinary Shares have no expiration date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HUMANA INC
Report date September 01, 2021 · Filed September 01, 2021
Section 16 reporting ended · disclosed 2021-09-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Humana CommonSEC Table I · non-derivative | Direct | 8,168 |
Reported balance
Holding disclosure · report date 2021-09-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 8,168 |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $217.42 · Expires 2024-03-08 | Direct | 459 |
Reported balance
Holding disclosure · report date 2021-09-01 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 459 F1: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 12,998 options vesting in three annual increments, and 6,499 options fully vest three years from the date of grant. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $268.47 · Expires 2025-02-19 | Direct | 6,623 |
Reported balance
Holding disclosure · report date 2021-09-01 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 6,623 F2: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/19/18, vesting in three increments from 02/19/19 to 02/19/21. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $307.97 · Expires 2026-02-25 | Direct | 6,106 |
Reported balance
Holding disclosure · report date 2021-09-01 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 6,106 F3: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/25/19, vesting in three increments from 02/25/20 to 02/25/22. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $350.79 · Expires 2027-02-24 | Direct | 6,088 |
Reported balance
Holding disclosure · report date 2021-09-01 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 6,088 F4: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23. |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $376.61 · Expires 2028-02-22 | Direct | 4,598 |
Reported balance
Holding disclosure · report date 2021-09-01 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 4,598 F5: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 460 |
Reported balance
Holding disclosure · report date 2021-09-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 460 F6: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under Company's 2011 Plan. F8: Restricted stock units granted to reporting person on 02/25/19, 33% of the award is vesting on 12/15/19, 12/15/20, and 12/15/21. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 808 |
Reported balance
Holding disclosure · report date 2021-09-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 808 F7: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F9: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,117 |
Reported balance
Holding disclosure · report date 2021-09-01 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 1,117 F7: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F10: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23. |
Filing footnotes · ownership attribution and instrument terms
F1: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017. 12,998 options vesting in three annual increments, and 6,499 options fully vest three years from the date of grant.
F2: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/19/18, vesting in three increments from 02/19/19 to 02/19/21.
F3: Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/25/19, vesting in three increments from 02/25/20 to 02/25/22.
F4: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.
F5: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.
F6: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under Company's 2011 Plan.
F7: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
F8: Restricted stock units granted to reporting person on 02/25/19, 33% of the award is vesting on 12/15/19, 12/15/20, and 12/15/21.
F9: Restricted stock units granted to reporting person on 02/24/2020, 33% of the award is vesting on 12/15/20, 12/15/21, and 12/15/22.
F10: Restricted stock units granted to reporting person on 02/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2017 Filed Feb 22, 2017 23:53 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 7,889 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000031 · edgar.xml · nonDerivative · entry 1 HUNTER CHRISTOPHER H. · CIK 0001595519 · SVP and Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · shares: Includes both time based (2,447) and performance based (5,442) restricted stock units that vested on 2/18/17. Read SEC document |
| January 06, 2017 Filed Jan 10, 2017 18:48 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 14,827 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000011 · edgar.xml · derivative · entry 6 HUNTER CHRISTOPHER H. · CIK 0001595519 · SVP and Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Humana Common · 14,827 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under Company's 2011 Plan. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under Company's 2011 Plan. F5 · derivative.exercise_date: Restricted stock units granted to Reporting Person on 01/06/14, 100% of the award is vesting on 01/06/17. F5 · derivative.expiration_date: Restricted stock units granted to Reporting Person on 01/06/14, 100% of the award is vesting on 01/06/17. Read SEC document |
| January 06, 2017 Filed Jan 10, 2017 18:48 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 6,576 | $201.25 | $1,323,436.44 |
DisclosureSEC source: 0000049071-17-000011 · edgar.xml · nonDerivative · entry 2 HUNTER CHRISTOPHER H. · CIK 0001595519 · SVP and Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,966 Read SEC document |
| January 06, 2017 Filed Jan 10, 2017 18:48 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 14,827 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-17-000011 · edgar.xml · nonDerivative · entry 1 HUNTER CHRISTOPHER H. · CIK 0001595519 · SVP and Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 18:14 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionRestricted Stock Units · Derivative | 1,092 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-16-000193 · edgar.xml · derivative · entry 8 HUNTER CHRISTOPHER H. · CIK 0001595519 · SVP and Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,186 Underlying: Humana Common · 1,092 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under Company's 2011 Plan. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under Company's 2011 Plan. F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18. F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 18:14 UTC | HUMANA INC HUM · Entity 1429 | Tax withholdingHumana Common | 377 | $206.60 | $77,886.32 |
DisclosureSEC source: 0000049071-16-000193 · edgar.xml · nonDerivative · entry 2 HUNTER CHRISTOPHER H. · CIK 0001595519 · SVP and Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 715 Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 18:14 UTC | HUMANA INC HUM · Entity 1429 | Exercise / conversionHumana Common | 1,092 | $0.00 | $0.00 |
DisclosureSEC source: 0000049071-16-000193 · edgar.xml · nonDerivative · entry 1 HUNTER CHRISTOPHER H. · CIK 0001595519 · SVP and Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,092 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.